Kourosh Shahkarami
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kourosh Shahkarami has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Abbas Aliaghaei
Genomic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
1 shared publication - Ali Asadi Zeidabadi
Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
1 shared publication - Amir Masoud Dalband
Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
1 shared publication - Amir-Hossein Bayat
Department of Basic Sciences, Saveh University of Medical Sciences, Saveh, Iran
1 shared publication - Amirreza Beirami
Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
1 shared publication - Armin Alinezhad
Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
1 shared publication
Latest Publications
- Open Access
- 31 October 2026
- Published by Brieflands in Journal of Cellular & Molecular Anesthesia
- Vol. 11 (3) , e174420
Association of Serum 25-Hydroxyvitamin D Levels with Diabetic Foot Ulcer: A Case-Control Study
Background: A diabetic foot ulcer (DFU) remains a major cause of morbidity, mortality, hospitalization, and lower-extremity amputation despite advances in diabetes mellitus management, imposing a substantial financial burden on health systems. Objectives: This study aimed to determine serum 25-hydroxyvitamin D [25(OH)D] levels in patients with type 2 diabetes mellitus (T2DM) and to compare clinical and laboratory parameters between patients with and without an active DFU. Methods: A case-control study was conducted at Imam Hossein Educational and Medical Center, Shahid Beheshti University of Medical Sciences. During 2024 - 2026, 200 patients with T2DM were recruited, including 102 with chronic DFU (cases) and 98 without DFU (controls). Demographic, clinical, and laboratory data were extracted from medical records and the hospital information system. Results: The mean age was 63.6 years among cases and 63.1 years among controls (P = 0.158). Body mass index was significantly higher in cases than in controls (28.0 ± 1.2 vs. 26.2 ± 0.9 kg/m2; P < 0.001). Diabetes duration was longer in patients with DFU (10 vs. 6.5 years; P = 0.02). Systolic blood pressure and blood urea nitrogen levels were significantly higher in the DFU group, and serum creatinine levels were also higher. Patients with DFU had significantly lower serum 25(OH)D levels than controls (19.82 ± 3.1 vs. 25.08 ± 2.4 ng/mL; P < 0.001). Conclusions: Lower serum 25(OH)D levels were associated with DFU and a less favorable clinical profile, including higher blood pressure and impaired renal function. Routine assessment of vitamin D status and targeted supplementation may be considered a cost-effective adjunctive strategy in the multidisciplinary management of patients with T2DM.
- 31 October 2026
- Published by Brieflands in Journal of Cellular & Molecular Anesthesia
- Vol. 11 (3) , e174420
Open AccessAssociation of Serum 25-Hydroxyvitamin D Levels with Diabetic Foot Ulcer: A Case-Control Study
Background: A diabetic foot ulcer (DFU) remains a major cause of morbidity, mortality, hospitalization, and lower-extremity amputation despite advances in diabetes mellitus management, imposing a substantial financial burden on health systems. Objectives: This study aimed to determine serum 25-hydroxyvitamin D [25(OH)D] levels in patients with type 2 diabetes mellitus (T2DM) and to compare clinical and laboratory parameters between patients with and without an active DFU. Methods: A case-control study was conducted at Imam Hossein Educational and Medical Center, Shahid Beheshti University of Medical Sciences. During 2024 - 2026, 200 patients with T2DM were recruited, including 102 with chronic DFU (cases) and 98 without DFU (controls). Demographic, clinical, and laboratory data were extracted from medical records and the hospital information system. Results: The mean age was 63.6 years among cases and 63.1 years among controls (P = 0.158). Body mass index was significantly higher in cases than in controls (28.0 ± 1.2 vs. 26.2 ± 0.9 kg/m2; P < 0.001). Diabetes duration was longer in patients with DFU (10 vs. 6.5 years; P = 0.02). Systolic blood pressure and blood urea nitrogen levels were significantly higher in the DFU group, and serum creatinine levels were also higher. Patients with DFU had significantly lower serum 25(OH)D levels than controls (19.82 ± 3.1 vs. 25.08 ± 2.4 ng/mL; P < 0.001). Conclusions: Lower serum 25(OH)D levels were associated with DFU and a less favorable clinical profile, including higher blood pressure and impaired renal function. Routine assessment of vitamin D status and targeted supplementation may be considered a cost-effective adjunctive strategy in the multidisciplinary management of patients with T2DM.
- 25 April 2026
- Published by Springer Nature in 3 Biotech
- Vol. 16 (5) , 169
The black barberry diet decreases oxidative stress and improves behavioral functions in adult male rats induced tramadol neurodegeneration: behavioral, molecular and histopathological studies
Tramadol has been classified as a prohibited substance in several countries due to a significant rise in overdoses and related deaths over the past decade. Black barberry (BB) has demonstrated therapeutic potential in various conditions, including metabolic, neurodegenerative, and cardiovascular disorders. This study investigated the protective effects of BB against tramadol-induced cognitive and neural impairments. Thirty-six rats were divided into three groups: control, tramadol (50 mg/kg daily for 21 days with a standard diet), and Tramadol + BB (same tramadol dose plus a diet containing 4% BB for 21 days). Behavioral tests—including the Y-maze, tail suspension, elevated plus maze, and Morris water maze—were conducted. Electrophysiological recordings, immunohistochemistry for GFAP, stereological analysis, neuronal spatial arrangement, and Western blotting were also performed. The BB-supplemented diet significantly improved memory performance in the Tramadol + BB group compared to tramadol-only rats. Field potential analysis showed recovery of the fEPSP slope to near-control levels. Western blot results indicated increased expression of brain-derived neurotrophic factor (BDNF) and repressor element 1-silencing transcription factor (REST) in the hippocampus. BB also reduced tramadol-induced astrogliosis, although astrocyte morphology was largely unchanged except for a decrease in branch number. Additionally, BB enhanced glutathione (GSH) levels and reduced reactive oxygen species (ROS). These findings suggest that BB mitigates tramadol-induced neurotoxicity, potentially through its antioxidant properties and modulation of REST and BDNF pathways. Further research is needed to clarify the molecular mechanisms underlying these protective effects.
- 25 April 2026
- Published by Springer Nature in 3 Biotech
- Vol. 16 (5) , 169
The black barberry diet decreases oxidative stress and improves behavioral functions in adult male rats induced tramadol neurodegeneration: behavioral, molecular and histopathological studies
Tramadol has been classified as a prohibited substance in several countries due to a significant rise in overdoses and related deaths over the past decade. Black barberry (BB) has demonstrated therapeutic potential in various conditions, including metabolic, neurodegenerative, and cardiovascular disorders. This study investigated the protective effects of BB against tramadol-induced cognitive and neural impairments. Thirty-six rats were divided into three groups: control, tramadol (50 mg/kg daily for 21 days with a standard diet), and Tramadol + BB (same tramadol dose plus a diet containing 4% BB for 21 days). Behavioral tests—including the Y-maze, tail suspension, elevated plus maze, and Morris water maze—were conducted. Electrophysiological recordings, immunohistochemistry for GFAP, stereological analysis, neuronal spatial arrangement, and Western blotting were also performed. The BB-supplemented diet significantly improved memory performance in the Tramadol + BB group compared to tramadol-only rats. Field potential analysis showed recovery of the fEPSP slope to near-control levels. Western blot results indicated increased expression of brain-derived neurotrophic factor (BDNF) and repressor element 1-silencing transcription factor (REST) in the hippocampus. BB also reduced tramadol-induced astrogliosis, although astrocyte morphology was largely unchanged except for a decrease in branch number. Additionally, BB enhanced glutathione (GSH) levels and reduced reactive oxygen species (ROS). These findings suggest that BB mitigates tramadol-induced neurotoxicity, potentially through its antioxidant properties and modulation of REST and BDNF pathways. Further research is needed to clarify the molecular mechanisms underlying these protective effects.